Summit Therapeutics Overview
Summit Therapeutics Target Price
Analysts' 12-month price predictions for SMMT.
Get informed when a big investor buys or sells
+ FollowShare Price
$13.81
Average Target Price
$19.50
41.2% upside
41.2% upside2 analysts in the last 4 months
High: $23 | Low: $16
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-04 | H.C. Wainwright | $23 | 66.5% upside |  |
| 2026-05-01 | Piper Sandler | $16 | 15.9% upside | |
| 2026-02-24 | H.C. Wainwright | $30 | 117.2% upside | |
| 2026-01-14 | Piper Sandler | $40 | 189.6% upside | |
| 2025-12-17 | Summit Redstone PartnersEtzer Darout | $18 | 30.3% upside | |
| 2025-10-21 | H.C. Wainwright | $40 | 189.6% upside | |
| 2025-10-21 | Barclays | $16 | 15.9% upside | |
| 2025-09-16 | Summit Redstone Partners | $13 |  5.9% downside | |
| 2025-08-19 | Summit Redstone PartnersKelsey Goodwin | $21 | 52.1% upside | |
| 2025-04-28 | H.C. Wainwright | $44 | 218.6% upside | |
| 2025-04-25 | Wells Fargo | $30 | 117.2% upside | |
| 2025-04-25 | JefferiesKelly Shi | $44 | 218.6% upside | |
| 2025-03-26 | Summit Redstone PartnersYigal Nochomovitz | $35 | 153.4% upside | |
| 2025-02-28 | Summit Redstone Partners | $42 | 204.1% upside | |
| 2024-11-04 | JMP SecuritiesReni Benjamin | $32 | 131.7% upside | |
| 2024-09-27 | Summit Redstone PartnersYigal Nochomovitz | $23 | 66.5% upside | |
| 2024-09-25 | Stifel NicolausBrad Canino | $40 | 189.6% upside | |
| 2024-09-16 | H.C. WainwrightMitchell Kapoor | $45 | 225.9% upside | |
| 2024-06-03 | Stifel NicolausBrad Canino | $14 | 1.4% upside | |
| 2024-03-25 | Stifel NicolausBrad Canino | $8 | 42.1% downside | |